We are live on
!
Find out more
KAM
Kazazian Asset Management Portfolio holdings
AUM
$91.5M
1-Year Est. Return
35.36%
This Fund
S&P 500
This Quarter
Est. Return
+4.5%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$13.7M
(+14%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
10.79%
Top 10 Holdings %
Top 10 Hldgs %
52.61%
Holding
94
New
9
Increased
24
Reduced
52
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.81M |
| 2 |
DigitalBridge
DBRG
|
+$2.26M |
| 3 |
Biogen
BIIB
|
+$2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$1.65M |
| 5 |
Global X MLP ETF
MLPA
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$2.11M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11M |
| 3 |
Intel
INTC
|
+$1.08M |
| 4 |
Nektar Therapeutics
NKTR
|
+$627K |
| 5 |
Chipotle Mexican Grill
CMG
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.98% |
| 2 | Financials | 10.74% |
| 3 | Consumer Discretionary | 9.86% |
| 4 | Communication Services | 6.92% |
| 5 | Energy | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $11.8M | 10.83% |
272,688
+60,688
| +29% | +$2.81M |
|
2
General Motors
GM
$80B
| $8.04M | 7.37% |
203,951
+35,974
| +21% | +$1.42M |
|
|
3
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $7.53M | 6.9% |
27,746
-4,106
| -13% | -$1.11M |
|
|
4
Biogen
BIIB
$30.7B
| $6.39M | 5.86% |
22,032
+7,103
| +48% | +$2M |
|
|
5
DigitalBridge
DBRG
$2.93B
| $5.35M | 4.9% |
214,178
+94,741
| +79% | +$2.26M |
|
6
Alphabet (Google) Class C
GOOG
$4.08T
| $4.39M | 4.02% |
78,700
+5,500
| +8% | +$297K |
|
7
Citigroup
C
$222B
| $3.81M | 3.49% |
56,860
+8,174
| +17% | +$563K |
|
8
Apple
AAPL
$4.9T
| $3.57M | 3.28% |
77,200
-5,320
| -6% | -$241K |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.29M | 3.01% |
26,494
+3,211
| +14% | +$375K |
|
|
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.21M | 2.94% |
70,498
+33,969
| +93% | +$1.65M |
|
11
Bausch Health
BHC
$2.25B
| $3.13M | 2.87% |
134,784
+18,814
| +16% | +$389K |
|
|
12
Global X MLP ETF
MLPA
$2.28B
| $2.77M | 2.54% |
50,398
+27,395
| +119% | +$1.5M |
|
13
Bristol-Myers Squibb
BMY
$132B
| $1.87M | 1.72% |
33,835
+15,114
| +81% | +$816K |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $1.84M | 1.69% |
29,036
+390
| +1% | +$31K |
|
|
RESI
15
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.7M | 1.56% |
163,329
-22,637
| -12% | -$235K |
|
16
Baidu
BIDU
$36.5B
| $1.6M | 1.47% |
6,601
+549
| +9% | +$137K |
|
17
Barclays
BCS
$93.4B
| $1.53M | 1.4% |
159,189
-8,728
| -5% | -$94.5K |
|
|
NS
18
DELISTED
NuStar Energy L.P.
NS
| $1.51M | 1.39% |
66,751
+6,733
| +11% | +$152K |
|
19
iShares MSCI Germany ETF
EWG
$1.6B
| $1.48M | 1.36% |
49,340
-3,061
| -6% | -$98.6K |
|
20
Alibaba
BABA
$279B
| $1.45M | 1.33% |
7,814
-499
| -6% | -$95.1K |
|
21
iShares Silver Trust
SLV
$28.6B
| $1.43M | 1.31% |
94,280
-9,135
| -9% | -$142K |
|
|
CS
22
DELISTED
Credit Suisse Group
CS
| $1.38M | 1.27% |
92,966
-5,098
| -5% | -$82.2K |
|
23
Expedia Group
EXPE
$35.2B
| $1.27M | 1.16% |
10,570
+3,851
| +57% | +$445K |
|
24
Walt Disney
DIS
$167B
| $1.26M | 1.15% |
+12,000
| New | +$1.23M |
|
|
AERI
25
DELISTED
Aerie Pharmaceuticals
AERI
| $1.19M | 1.09% |
17,650
-671
| -4% | -$37.5K |
|
Similar funds
MRP
ITG
AM
MA
PHIMC
AW
SPCM
JBL
Kazazian Asset Management's Q2 2018 Portfolio in Review
As of Q2 2018, Kazazian Asset Management held 94 positions worth $109M, up 14% from $95.4M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Kazazian Asset Management deployed $11.8M of net new capital in Q2 2018, opening 9 new positions and adding to 24 existing holdings. Its largest new stake was Walt Disney: 12,000 shares worth $1.26M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11M trimmed.
- Kazazian Asset Management's largest Q2 2018 buy was Walt Disney: 12,000 shares worth $1.26M.
- Kazazian Asset Management added most to iShares MSCI Emerging Markets ETF in Q2 2018, an estimated $2.81M increase.
- Kazazian Asset Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11M.
- Kazazian Asset Management fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q2 2018, selling an estimated $2.11M.
- Kazazian Asset Management's ten largest holdings make up 53% of its $109M portfolio in Q2 2018.
- Kazazian Asset Management opened 9 new positions and closed 6 in Q2 2018.
- Kazazian Asset Management's portfolio value rose 14% quarter-over-quarter to $109M.
Based on Kazazian Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.